Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic active hepatitis associated with etretinate therapy.

V C Weiss, T Layden, A Spinowitz

    The British Journal of Dermatology
    |May 1, 1985
    PubMed
    Summary

    Etretinate treatment for psoriasis can lead to acute hepatitis, potentially progressing to chronic active hepatitis. This case highlights the risk of significant liver disease in patients undergoing etretinate therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Incidence of cutaneous adverse events after exposure to tenofovir-emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Frequency of acne in lactose-intolerant adults: a retrospective cross-sectional analysis within a large Midwestern US patient population.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non-melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2018
    Same author

    Reply to-chronic exposure to tetracyclines and subsequent diagnosis for non-melanoma skin cancer in a large Midwestern US population.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2017
    Same author

    Rosacea and subsequent diagnosis for Parkinson's disease: a large, urban, single center, US patient population retrospective study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2017

    Area of Science:

    • Hepatology
    • Immunology
    • Dermatology

    Background:

    • Etretinate is a retinoid used for severe psoriasis.
    • Hepatotoxicity is a known, though rare, side effect of etretinate.
    • Monitoring liver function is crucial during etretinate therapy.

    Observation:

    • A patient with severe psoriasis developed acute hepatitis while on etretinate.
    • Histological liver changes progressed to chronic active hepatitis after discontinuing etretinate.
    • This represents the third reported case of chronic active hepatitis linked to etretinate.

    Findings:

    • The patient showed increased OKMI-staining peripheral mononuclear cells.
    • Concanavalin A-induced lymphocyte blastogenesis was augmented by etretinate.

    Related Experiment Videos

  • Immunological changes may play a role in etretinate-induced liver injury.

    • Implications:

    • Etretinate therapy carries a risk of severe, progressive liver disease.
    • Further research into the immunological mechanisms of etretinate hepatotoxicity is warranted.
    • Clinicians should be vigilant for hepatic complications in patients treated with etretinate.